Real-time enrollment status for this germ cell tumor clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 12:02 PM UTC
| NCT Number | NCT04804007 |
| Recruiting Status | Recruiting |
| Condition | Germ Cell Tumor |
| Phase | PHASE2 |
| Target Enrollment | 64 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Nabil Adra |
| Last Updated on CT.gov | May 8, 2026 (May 8, 2026) |
As of August 28, 2026: Clinical trial NCT04804007 is currently recruiting participants. This phase2 study for germ cell tumor is actively seeking new participants at 1 location across the United States. The study is sponsored by Nabil Adra. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04804007 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04804007 was last updated May 8, 2026 (May 8, 2026). HelloStudys verifies this status automatically.